LaingBuisson announces 2020 finalists

Re:Cognition Health Shortlisted for Three Awards

LaingBuisson announces 2020 finalists 

Re:Cognition Health is delighted to be shortlisted in three categories of the LaingBuisson Awards, 2020.

These prestigious health and social care awards have celebrated  excellence in the health and social care industries, since 2005.

Our inspirational  CEO Dr Emer MacSweeney has been shortlisted in the Rising Star category. Dr MacSweeney co-founded Re:Cognition Health in 2011 with the vision of addressing the  global challenge of Alzheimer’s disease and a

determination  to provide the most accurate early diagnosis for individuals, of all ages, suffering from cognitive conditions affecting their brains and minds. Today, Dr MacSweeney has achieved this through Re:Cognition Health, by providing access to the latest, most advanced diagnostics and treatments, available globally,  to slow, or halt, the progression of these conditions. Dr MacSweeney has also lead Re:Cognition Health to be the fastest growing, company, internationally, for clinical delivery for international clinical trials for Alzheimer’s and related causes of dementia.

Re:Cognition Health (RCH) has also been shortlisted in the Primary Care & Diagnostics category, which recognises excellence in healthcare services  and Healthcare Outcomes category which demonstrates the delivery of better healthcare outcomes. Our team at Re:Cognition Health are united in their ambition to find new treatments and cures for Alzheimer’s disease and other neurodegenerative and neurodevelopment diseases and traumatic brain injury.  RCH is changing the future, for our patients by  putting their  needs first, ensuring safety, health and outcomes are prioritised at every stage of the journey.

We are so thrilled to be finalists in the LaingBuisson Awards 2020 amongst the most innovative healthcare providers and services in the UK. We are very much looking forward to celebrating with the industry in November. Congratulations and good luck to all of the finalists.